Medical News

RSS

Symphogen to present second-generation Sympress platform at ESACT conference

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.

11 May 2011

HBA to host panel discussion on Accountable Care Organizations

Accountable Care Organizations: Accountable? Affordable? Achievable?—A panel discussion presented by the Southern California HBA featuring a distinguished group of local healthcare industry leaders.

11 May 2011

Identigene announces availability of DNA paternity test kit in New York drug stores

Identigene today announced that the Identigene DNA Paternity Test Kit is now available in chain drug stores and independent pharmacies throughout the state of New York, expanding sales from 260 retail locations in the New York City area to more than 1,600 stores across the state.

11 May 2011

Naurex announces completion of $18 million Series A financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.

11 May 2011

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.

11 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Challenges to health law take center stage with appellate court action

President Obama's health care law faces a series of challenges in three appeals courts starting Tuesday as Republican lawyers from 27 states will urge the courts to strike down the law as unconstitutional. In a sign of the high stakes and the partisan divide, one case will feature a rare courtroom clash between the Obama administration's top appellate lawyer and his counterpart from the George W. Bush administration.

11 May 2011

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment

The Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals, Inc. announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes.

11 May 2011

Impax Pharmaceuticals initiates IPX159 Phase I study in Restless Legs Syndrome

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced the successful filing of an Investigational New Drug Application for IPX159 in Restless Legs Syndrome and initiated a Phase I study.

11 May 2011

Heart docs dismiss bias claims stemming from industry support of meeting

Doctors said the heart society meeting was an important opportunity to learn about new research in their field and see new products on the market. Unlike in many other areas of medicine, they said, electrophysiologists work hand-in-hand with device company representatives to program implantable defibrillators and diagnose problems.

11 May 2011

Engineers develop novel hybrid HMI for hands-free control of electric powered wheelchairs

For people with severe physical disabilities, such as spinal cord injury, quadriplegia and hemiplegia or amputation, current technology for controlling a wheelchair or mobility scooter is wholly inadequate.

11 May 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that GATTEX, a novel, recombinant analog of human glucagon-like peptide 2, was found to effectively and safely reduce parenteral support volume in adult short bowel syndrome-intestinal failure patients.

11 May 2011

ICON partners with BCRI for clinical research

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic alliance with Boston Clinical Research Institute, an Academic Research Organisation based in Boston, Massachusetts.

11 May 2011

Study: Many patients screened for colon cancer more often than recommended

Many patients are getting screened for colorectal cancer more often than guidelines recommend, hints a new study.

11 May 2011

Common tiny tropical fish plays a key role in new model for Cushing disease

A common, tiny tropical fish plays a key role in a new model for Cushing disease, giving researchers a powerful tool to conduct extensive searches for effective treatments for this serious hormonal disorder, testing up to 300 drugs weekly.

11 May 2011

Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50

Thermo Fisher Scientific, the world leader in serving science, is confident in being able to secure all necessary outstanding regulatory and antitrust approvals in connection with its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation for $118.50 per share in cash.

From Thermo Fisher Scientific Inc. 11 May 2011

Medicare, entitlement reform continue to trigger political rifts

The AP reports that, as unlikely as it may seem, the Obama administration and congressional Republicans may share some common ideas regarding Medicare costs. Still, the issue of how to address the programs — and the related proposals — still are causing rifts within the GOP.

11 May 2011

NAA calls for immediate Congressional hearings and scientific investigation into autism-vaccine link

Despite numerous studies cited repeatedly by federal officials as proof that vaccines do not cause autism, a new study released today in the Pace Environmental Law Review revealed that over the last two decades, the National Vaccine Injury Compensation Program has been quietly compensating dozens of vaccine injury cases involving a child with autism.

11 May 2011

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 2011 Digestive Disease Week conference highlighting additional analyses of data from Phase 3 trials of DIFICID, an investigational product for the treatment of Clostridium difficile infection.

11 May 2011

Georgia to review Medicaid changes; Calif. judge rules against freeze on payments for disability services

In any other year, a historic overhaul of the Medicaid system would have overshadowed every health issue in the Legislature. But when lawmakers went home early Saturday morning, Medicaid might not have even been the noisiest health-related debate of the 2011 legislative session. Lawmakers passed a nearly $70 billion budget that included deep cuts to hospitals, nursing homes and dozens of other health programs.

11 May 2011

Medical News

Symphogen to present second-generation Sympress platform at ESACT conference

HBA to host panel discussion on Accountable Care Organizations

Identigene announces availability of DNA paternity test kit in New York drug stores

Naurex announces completion of $18 million Series A financing

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Challenges to health law take center stage with appellate court action

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment

Impax Pharmaceuticals initiates IPX159 Phase I study in Restless Legs Syndrome

Heart docs dismiss bias claims stemming from industry support of meeting

Engineers develop novel hybrid HMI for hands-free control of electric powered wheelchairs

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

ICON partners with BCRI for clinical research

Study: Many patients screened for colon cancer more often than recommended

Common tiny tropical fish plays a key role in new model for Cushing disease

Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50

Medicare, entitlement reform continue to trigger political rifts

NAA calls for immediate Congressional hearings and scientific investigation into autism-vaccine link

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Georgia to review Medicaid changes; Calif. judge rules against freeze on payments for disability services

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News